Chief Executive Officer Bob Bradway told attendees at a J.P. Morgan-hosted event that the company views 2026 as a “springboard year,” driven in part by what he described as a significant amount of ...

AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...

Amgen's experimental drug MariTide shows promise in maintaining weight loss and lowering blood sugar in diabetes patients.

Amgen's study of the drug Maritide in people with Type 2 diabetes showed noteworthy reductions in HbA1c and weight. The ...

An extension study of Amgen's experimental obesity drug MariTide found that it helped people maintain weight loss while a ...

Pill versions of the successful GLP1 drugs from Novo Nordisk and Eli Lilly will likely be on the market in 2026’s first half.

Amgen's research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on ...

The atherosclerotic cardiovascular disease market in the 7MM is expected to show positive growth during the forecast period (2025–2034), mainly attributed to the launch of upcoming therapies such as ...

CARY, NC, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- The CEO Roundtable on Cancer (CEORT) today announced ...

"6 in '26" expected proof-of-concept (POC) readouts across SKYLINE and SKYWAY trials SKYLINE platform trial in ulcerative colitis (UC) recruiting faster than expected with SPY001 enrollment complete ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval ...

President Trump’s self-branded attempt to cut drug prices, TrumpRx, is set to launch within weeks, offering a novel pathway ...